Professor Bruce Rasmussen
Director, Victoria Institute of Strategic Economic Studies
Professor Rasmussen is Director of Victoria Institute of Strategic Economic Studies (VISES), having joined the Institute in 1998.
His work has focussed on innovation, business models, business strategy and industry development issues. His most recent work has been on health and productivity and the economic returns to investment in health, for the US Chamber of Commerce, WHO and UNFPA.
Professor Rasmussen has had a career spanning the senior levels of both the public and private sectors. In Government he has held a number of senior positions, most significantly as Assistant Director General, Finance in the Department of Management and Budget of the State of Victoria.
He spent seven years at the ANZ Bank, where he held various senior business strategy roles, most notably as Chief Manager, Retail Strategy in the Retail Bank and Chief Manager, Development of the Private Bank.
In 2008 Professor Rasmussen completed a health study on The Creation and Capture of Value in Biopharmaceuticals which is being published as a book by Edward Elgar (2010).
He holds a Master of Public Administration (MPA) from the Kennedy School of Government at Harvard University, where he graduated as a Littauer Fellow - awarded on the basis of academic excellence, career and leadership.
Rasmussen, B. (2010), Innovation and Commercialisation in the Biopharmaceutical Sector: Creating and Capturing Value, Edward Elgar, London.
Bertram, M.Y., Sweeny, K., Lauer, J.A., Chisholm, D., Sheehan, P., Rasmussen, B., Upreti, S.R., Dixit, L.P., George, K. and Deane, S. (2018), ‘Investing in non-communicable diseases: An estimation of the return on investment for prevention and treatment services’, Lancet, 4 April 2018, DOI: https://doi.org/10.1016/S0140-6736(18)30665-2
Patton, G.C., Olsson, C.A., Skirbekk, V., Saffery, R., Wlodek, M.E., Azzopardi, P.S., Stonawski, M., Rasmussen, B., Spry, E., Francis, K., Bhutta, Z.A., Kassebaum, N.J., Mokdad, A.H., Murray, C.J.L., Prentice, A.M., Reavley, N., Sheehan, P., Sweeny, K., Viner, R.M., Sawyer, S.M. (2018), ‘Adolescence and the next generation’, Nature, vol. 554, pp. 458-467, https://www.nature.com/articles/nature25759
Sheehan, P., Sweeny, K., Rasmussen, R., Wils, A., Friedman, H.S., Mahon, J., Patton, G.C., Sawyer, S.M., Howard, E., Symons, J., Stenberg, K., Chalasani, S., Maharaj, N., Reavley, N., Shi, H., Fridman, M., Welsh, A., Nsofor, E. and Laski, L. (2017) 'Building the foundations for sustainable development: A case for global investment in the capabilities of adolescents', The Lancet, online 19 April 2017, DOI: http://dx.doi.org/10.1016/S0140-6736(17)30872-3
Chisholm, D., Sweeny, K., Sheehan, P., Rasmussen, B., Smit, F., Cuijpers, P. and Saxena, S. (2016) 'Scaling-up treatment of depression and anxiety: A global return on investment analysis', Lancet Psychiatry, vol. 3, no. 5, pp. 415-424, http://dx.doi.org/10.1016/S2215-0366(16)30024-4
Stenberg, K., Axelson, H., Sheehan, P., Anderson, I., Gülmezoglu, A.M., Temmerman, M., Mason, E., Friedman, H.S., Bhutta, Z.A., Lawn, J.E., Sweeny, K., Tulloch, J., Hansen, P., Chopra, M., Gupta, A., Vogel, J.P., Ostergren, M., Rasmussen, B., Levin, C., Boyle, C., Kuruvilla, S., Koblinsky, M., Walker, N., de Francisco, A., Novcic, N., Presern, C., Jamison, D. and Bustreo, F. on behalf of the Study Group for the Global Investment Framework for Women’s Children’s Health (2014) ‘Advancing social and economic development by investing in women's and children's health: A new global investment framework’, The Lancet, 383(9925) 1333-1354.
Rasmussen, B. (2007) ‘Is the commercialisation of nanotechnology different? A case study approach’, Innovation: Management, Policy and Practice, 9(1).
Areas of expertise
- Business models
- Business strategy
- Industry development